Adverse Events | Events | Events/100PY |
---|---|---|
Total adverse events leading to discontinuation | 73 | 9.00 |
Skin disorders | 16 | 1.97 |
Blood disorders | 4 | 0.49 |
Infectious diseases | 21 | 2.59 |
Tuberculosis | 3 | 0.37 |
Pneumocystis pneumonia | 1 | 0.12 |
Organizing pneumonia | 2 | 0.25 |
Interstitial pneumonia | 3 | 0.37 |
Liver disorders | 3 | 0.37 |
Malignant lymphoma | 1 | 0.12 |
Solid cancer | 2 | 0.25 |
PY: patient-years.